DIALOQ Trademark

Trademark Overview

On Thursday, April 26, 2018, a trademark application was filed for DIALOQ with the United States Patent and Trademark Office. The USPTO has given the DIALOQ trademark a serial number of 79238809. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 15, 2025. This trademark is owned by Novo Nordisk A/S. The DIALOQ trademark is filed in the Medical Instrument Products category with the following description:

Digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with diabetes and obesity management
dialoq

General Information

Serial Number79238809
Word MarkDIALOQ
Filing DateThursday, April 26, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 15, 2025
Registration Number5663844
Registration DateTuesday, January 29, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 13, 2018

Trademark Statements

Goods and ServicesDigitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with diabetes and obesity management

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status CodeF - NOT AVAILABLE
Class Status DateSaturday, August 16, 2025
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk A/S
Party Type30 - Original Registrant
Legal Entity Type65 - NOT AVAILABLE
AddressDK
Party NameNovo Nordisk A/S
Party Type20 - Owner at Publication
Legal Entity Type65 - NOT AVAILABLE
AddressDK
Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type65 - NOT AVAILABLE
AddressDK

Trademark Events

Event DateEvent Description
Thursday, August 23, 2018NON-FINAL ACTION WRITTEN
Thursday, August 16, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, August 21, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 21, 2018ASSIGNED TO EXAMINER
Friday, August 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 24, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, August 25, 2018APPLICATION FILING RECEIPT MAILED
Saturday, August 25, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 3, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 3, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 4, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 6, 2018REFUSAL PROCESSED BY MPU
Thursday, September 6, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, September 21, 2018REFUSAL PROCESSED BY IB
Monday, September 24, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 24, 2018AMENDMENT FROM APPLICANT ENTERED
Monday, September 24, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 7, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 7, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, November 13, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, November 24, 2018NOTIFICATION PROCESSED BY IB
Tuesday, January 29, 2019REGISTERED-PRINCIPAL REGISTER
Monday, April 29, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, May 23, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 7, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, January 29, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 15, 2025CANCELLED SECTION 71
Wednesday, May 22, 2019FINAL DISPOSITION PROCESSED

Related Keywords

dialoq connection preparations diabetes obesity management pharmaceutical dispensation connected medical devices